Torsten Passie

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Peter Gasser, Dominique Holstein, Yvonne Michel et al. · The Journal of Nervous and Mental Disease · 2014 · 725 citations · Full text

Psychotropic Medication, State-trait Anxiety Inventory, Psychopharmacology +19

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

Peter Gasser, Katharina Kirchner, Torsten Passie · Journal of Psychopharmacology · 2014 · 438 citations

Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.

John H. Halpern, Torsten Passie, Kimberly C Blackwell et al. · PubMed · 2008 · 130 citations

The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)

Torsten Passie · Drug Science Policy and Law · 2018 · 113 citations · Full text

Psychotherapy, Psychotropic Medication, Psychopharmacology +22

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Matthias Karst, John H. Halpern, Michael Bernateck et al. · Cephalalgia · 2010 · 104 citations

Ch Relief, Preventative Treatment, Cluster Headache +13